Autoimmune addison's disease

Endocrine Development

Volumn 20, Issue , 2010, Pages 161-172

  Betterle, Corrado ^a   Morlin, Luca ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX AUTOANTIBODY; ANDROGEN; AUTOANTIBODY; BICARBONATE; BIOLOGICAL MARKER; CHLORIDE; CORTICOTROPIN; CORTISONE ACETATE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; POTASSIUM; SODIUM; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADRENAL CORTEX; ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; ARTICLE; AUTOIMMUNE ADDISON DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNE PARKINSON DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BICARBONATE BLOOD LEVEL; CELLULAR IMMUNITY; CHILDHOOD DISEASE; CHLORIDE BLOOD LEVEL; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN BLOOD LEVEL; DEVELOPED COUNTRY; DISEASE ASSOCIATION; DISEASE MARKER; ENVIRONMENTAL FACTOR; GENETIC DISORDER; HEREDITY; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMORAL IMMUNITY; IMAGING SYSTEM; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; NEOPLASM; NONHUMAN; PARKINSON DISEASE; PLASMA CELL; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; TUBERCULOSIS; VASCULAR DISEASE;

ADDISON DISEASE; ADULT; ANIMALS; AUTOIMMUNE DISEASES; CHILD; FEMALE; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; MINERALOCORTICOIDS; MODELS, BIOLOGICAL;

EID: 78751473070     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000321239     Document Type: Article

References (74)

1. Arlt W, Allolio B: Adrenal Insufficiency. Lancet 2003;361:1881.
2. Stuart-Mason A, Meade TW, Lee JAH, Morris JN: Epidemiological and clinical picture of Addisons disease. Lancet 1968;2:19.
3. Nerup J: Addisons disease - clinical studies. A report of 108 cases. Acta Endocrinol 1974;76:127.
4. Kong MF, Jeffocoate W: Eighty-six cases of Addisons disease. Clin Endocrinol (Oxf) 1994;41:757-761.
5. Willis AC, Vince FP: The prevalence of Addisons disease in Coventry, UK. Postgrad Med J 1997;73: 286.
6. Laureti S, Vecchi L, Santeusanio F, Falorni A: Is the prevalence of Addisons disease underestimated? J Clin Endocrinol Metab 1999;84:1762.
7. Lovas K, Husebye ES: High prevalence and increasing incidence of Addisons disease in western Norway. Clin Endocrinol (Oxf) 2002;56:787.
8. Erichsen MM, Lovas K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES: Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observation from a Norwegian registry. J Clin Endocrinol Metab 2009;94:4882.
9. Dunlop D: Eighty-six cases of Addisons disease. Br Med J 1963;3:887.
10. Cooper GS, Stroehla BC: The epidemiology of autoimmune diseases. Autoimmun Rev 2002;2:119.
11. Perry R, Kecha O, Paquette J, Vliet GV, Deal C: Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab 2005;90:3243.
12. McNicol AM, Laidler P: The adrenal glands and extra-adrenal paraganglia; in: Lewis PD, (ed): Endocrine System. N.Y, Churchill Livingstone, 1996 pp 59-129.
13. Rabinowe SL, Jackson RA, Dluhy RG, Williams GH: Ia-positive T lymphocytes in recently diagnosed idiopathic Addisons disease. Am J Med 1984; 77:597.
14. Freeman M, Weetman AP: T-and B-cell reactivity to adrenal antigens in autoimmune Addisons disease. Clin Exp Immunol 1992; 88:275.
15. Krieghel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz HM: Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004;199:1285.
16. Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES: T-cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J Clin Endocrinol Metab 2009;94:5117.
17. Andrada JA, Skelton FR, Andrada EC, Milgrom F, Witebsky E: Experimental autoimmune adrenalitis in rats. Lab Invest 1968;19:460.
18. Irino T, Grollman A: Induction of adrenal insufficiency in the rat by sensitization with homologous tissue. Metabolism 1968;17:717.
19. Levine S, Wenk EJ: The production and passive transfer of allergic adrenalitis. Am J Pathol 1968;52: 4120.
20. Harlton BW: Addisons disease in a dog. Vet Med Small Anim Clin 1976;71:285.
21. Kaufman J: Diseases of the adrenal cortex of dogs and cats. Mod Vet Pract 1984;65:513.
22. Little C, Marshall C, Downs J: Addisons disease in the dog. Vet Rec 1989;124:469.
23. Kintzer PP, Peterson ME: Diagnosis and management of primary spontaneous hypoadrenocorticism (Addisons disease) in dogs. Semin Vet Med Surg 1994;9:148.
24. Sadek D, Schaer M: Atypical Addisons disease in the dog: a retrospective survey 14 cases. J Am Anim Hosp Assoc 1996;32:159.
25. Dunn KJ, Herrtage ME: Hypocortisolaemia in a Labrador retriever. J Small Anim Pract 1998;39:90.
26. Peterson ME, Greco DS, Orth DN: Primary hypoadrenocorticism in ten cats. J Vet Intern Med 1989;3: 55.
27. Tasker S, MacKay AD, Sparkes AH: Case report. A case of feline primary hypoadrenocorticism. J Felin Med Surg 1999;1:257.
28. Stonehewer J, Tasker S: Hypoadrenocroticism in a cat. J Small Anim Pract 2001;42:186.
29. Beales PE, Castri F, Valiani A, Rosignoli G, Buckley L, Pozzilli P: Adrenalitis in the non-obese diabetic mouse. Autoimmunity 2002;35:329.
30. Anderson JR, Goudie RB, Gray KG, Timbury GC: Autoantibodies in Addisons disease. Lancet 1957;1:1123.
31. Blizzard RM, Kyle M: Studies on adrenal antigens and autoantibodies in Addisons disease. J Clin Invest 1963;42:1653.
32. Irvine WJ, Barnes EW: Addisons disease, ovarian failure and hypoparathyroidism. Clin Endocrinol Metab 1975;4:379.
33. Sotsiu F, Bottazzo GF, Doniach D: Immunofluorescence studies on autoantibodies to steroidproducing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol 1980; 39:97.
34. Betterle C: Addison disease and autoimmune polyglandular syndromes: in Geenen V, Chrosus G (eds): Immunoendocrinology in Health and Disease. New York, Dekker, 2004, chapt 24, pp 491- 536.
35. Baumann-Antczak A, Wedlock N, Bednarek J, Kiso Y, Krishnan H, Fowler S, Rees Smith B, Furmaniak J: Autoimmune Addisons disease and 21-hydroxylase. Lancet 1992;340:429.
36. Bednarek J, Furmaniak J, Wedlock N, Kiso Y, Baumann-Antczak A, Fowler S, Krishnan H, Craft JA, Rees Smith B: Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addisons disease. FEBS Lett 1992;309:51.
37. Winqvist O, Karlsson FA, Kampe O: 21-Hydroxylase, a major autoantigen in idiopathic Addisons disease. Lancet 1992;339:1559.
38. Colls J, Betterle C, Volpato M, Rees Smith B, Furmaniak J: A new immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in Addisons disease. Clin Chem 1995;41:375.
39. Falorni A, Nikoshokov A, Laureti S, Grenback E, Hulting AL, Casucci G: High diagnostic accuracy for idiopathic Addisons disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab 1995;80:2752.
40. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J: Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addisons disease, and premature ovarian failure. J Clin Endocrinol Metab 1996;83:2977.
41. Tanaka H, Perez MS, Powell M, Sandres JF, Sawicka J, Chen S, Prentice L, Asawa T, Betterle C, Volpato M, Rees Smith B, Furmaniak J: Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipations assay. J Clin Endocrinol Metab 1997;82:1440.
42. Betterle C, Dal Pra C, Mantero F, Zanchetta R: Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23:327.
43. Neufeld M, Blizzard RM: Polyglandular autoimmune diseases; in Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds): Symposium on Autoimmune Aspects of Endocrine Disorders. New York, Academic Press, 1980, pp 357-365.
44. Neufeld M, MacLaren NK, Blizzard RM: Two types of autoimmune Addisons disease associated with different polyglandular autoimmune syndromes. Medicine 1981;60:355.
45. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJE, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N: Positional cloning of the APECED gene. Nat Genet 1997;17:393.
46. The Finnish-German APECED Consortium: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zincfinger domains. Nat Genet 1997;17:399.
47. Mathis D, Benoist C: Aire. Annu Rev Immunol 2009;27:287-312.
48. Rosatelli MC, Meloni A, Devoto M, Cao A, Scott HS, Peterson P, Heino M, Krohn KJ, Nagamine K, Kudoh J, Shimizu N, Antonarakis SE: A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 1998;103:428.
49. Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, Pinchera A, Marcocci C: A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasisectodermal dystrophy, acting in a dominant fashion and strongly co-segregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 2001; 86:4747.
50. Meloni, A, Perniola R, Faa V, Corvaglia E, Cao A, Rosatelli MC: Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. J Clin Endocrinol Metab 2002;87:841.
51. De Luca F, Valenzise M, Alaggio R, Arrigo T, Crisafulli G, Salzano G, Cervato S, Mariniello B, Lazzarotto F, Betterle C: Sicilian family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and lethal lung disease in one of the affected brothers. Eur J Pediatr 2008;167:1283.
52. Cervato S, Mariniello B, Lazzarotto F, Morlin L, Zanchetta R, Radetti G, De Luca F, Valenzise M, Giordano R, Rizzo D, Giordano C, Betterle C: Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasisectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol (Oxf) 2009;70:421.
53. Betterle C, Lazzarotto F, Presotto F: Autoimmune polyglandular syndrome type 2: the tip of an iceberg? Clin Exp Immunol 2004;137:225.
54. Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H, Pearce SH, Watson PF, Weetman AP: A cytotoxic T-lymphocytic antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addisons disease in English patients. Clin Endocrinol (Oxf) 1998;49:609.
55. Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE: Polymorphisms in the cytotoxic T-lymphocyte antigen-4 gene region confer susceptibility to Addisons disease. J Clin Endocrinol Metab 2004;89: 3474.
56. Betterle C, Zanchetta R, Trevisan A, Zanette F, Pedini B, Mantero F, Rigon F: Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addisons disease. Lancet 1983;1: 1238.
57. Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F, Mantero F: The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988;117:467.
58. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Greggio NA, Sanzari M, Tedesco F, Pedini B, Boscaro M, Presotto F: I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addisons disease. J Clin Endocrinol Metab 1997;82:932.
59. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Zanchetta R, Greggio NA, Pedini B, Boscaro M, Presotto F: II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addisons disease. J Clin Endocrinol Metab 1997;82:939.
60. Laureti S, Arvat E, Candeloro P, Di Vito L, Ghigo E, Santeusanio F, Falorni A: Low dose (1 g) ACTH test in the evaluation of adrenal dysfunction in preclinical Addisons disease. Clin Endocrinol (Oxf) 2000; 53:107.
61. Betterle C, Coco G, Zanchetta R: Adrenal cortex autoantibodies in subjects with normal adrenal function. Best Pract Res Clin Endocrinol Metab 2005;19:85.
62. Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F, Betterle C: Estimated risk for developing autoimmune Addisons disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab 2006;91:1637.
63. Furmaniak J, Kominami S, Asawa T, Wedlock N, Colls J, Rees Smith B: Autoimmune Addisons disease. Evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. J Clin Endocrinol Metab 1994;79:1517.
64. Boscaro M, Betterle C, Volpato M, Fallo F, Furmaniak J, Rees Smith B, Sonino N: Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. J Clin Endocrinol Metab 1996;81:2801.
65. Betterle C, Dal Pra C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B: Assessment of adrenal function and adrenal autoantibodies in a baby of a mother with autoimmune polyglandular syndrome type 2. J Endocrinol Invest 2004;27:618.
66. Wulfraat NM, Drexhage HA, Bottazzo GF, Wiersinga WM, Jeucken P, Van der Gaag R: Immunoglobulins of patients with idiopathic Addisons disease block the in vitro action of adrenocotropin. J Clin Endocrinol Metab 1989;69:231.
67. Wardle CA, Weetman AP, Mitchell R, Peers N, Robertson WR: Adrenocorticotropic hormone receptor-blocking immunoglobulins in serum from patients with Addisons disease: a re-examination. J Clin Endocrinol Metab 1993;77:750.
68. Orth DN, Kavacs WJ: The adrenal cortex; in Wilson JD, Foster DW, Kronenberg HM, Larse PR (eds): Williams Textbook of Endocrinology, ed 9. Philadelphia, Saunders, 1998, pp 517-664.
69. Doppman JL: Adrenal imaging; in De Groot LJ, Jameson JL (eds): Endocrinology, ed 4. Philadelphia, Saunders, 2001, vol 125, pp 1747-1766.
70. Presotto F, Fornasini F, Betterle C, Federspil G, Rossato M: Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature. Eur J Endocrinol. 2005;153:507.
71. Burch WM: Urine free-cortisol determination: a useful tool in the management of chronic hypoadrenal states. JAMA 1982;247:2002.
72. Howlett TA: An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 1997;46:263.
73. Williams GH, Dluhy RG: Disease of the adrenal cortex; in Fauci AS, Braunwald E, Isselbacher KJ, et al (eds): Harrisons Principles of Internal Medicine, ed 14. New York, McGraw-Hill, 1998, pp 2040- 2042.
74. Oelkers W: Adrenal insufficiency. N Engl J Med 1996;335:1206.